Most linked-to pages
Appearance
Showing below up to 50 results in range #151 to #200.
- Phenotype:CYP2C19 normal metabolizer (7 links)
- Pharmacopedia:Sources (7 links)
- Valproic acid (7 links)
- Phenotype:CYP2C19 poor metabolizer (7 links)
- Category:SGLT2 inhibitors (7 links)
- Phenotype:CYP2C19 rapid metabolizer (7 links)
- Turmeric (7 links)
- Pharmacopedia:Terms of Use (7 links)
- Category:Sympathomimetics (7 links)
- Category:Selective Serotonin Reuptake Inhibitors (SSRIs) (7 links)
- Phenotype:CYP2C19 ultrarapid metabolizer (7 links)
- Category:Antifungals (7 links)
- Type 2 diabetes mellitus (7 links)
- Category:Opioids (7 links)
- Category:Sleep aids (7 links)
- Clozapine (7 links)
- Category:Vasopressors (7 links)
- Estradiol (7 links)
- Category:Thyroid hormones (7 links)
- Enzyme:NUDT15 (7 links)
- Dexmethylphenidate (7 links)
- Fluconazole (7 links)
- Sildenafil (7 links)
- Category:Beta-lactam antibiotics (7 links)
- Doxepin (7 links)
- Category:Osmotic laxatives (7 links)
- Enzyme:TPMT (7 links)
- Category:BPH treatments (7 links)
- Category:Hormonal contraceptives (7 links)
- Amiodarone (7 links)
- USLegal:DEA Schedule V (7 links)
- United States (7 links)
- Category:Serotonin–Norepinephrine Reuptake Inhibitors (SNRIs) (7 links)
- Clonazepam (7 links)
- Cocaine (7 links)
- Venlafaxine (7 links)
- Dextromethorphan (7 links)
- THC (7 links)
- Pharmacopedia:Reciprocity (7 links)
- Category:Prokinetics (7 links)
- Category:Antisecretory agents (7 links)
- Phenotype:CYP2D6 poor metabolizer (7 links)
- Category:Inhaled corticosteroids (7 links)
- Lisdexamfetamine (7 links)
- Category:H1 receptor antagonists (7 links)
- GLP-1 receptor (6 links)
- USLegal:Schedule II (6 links)
- Category:Fluoroquinolones (6 links)
- Alfentanil (6 links)
- Category:Antimalarials (6 links)